Does MTRR rs1801394 AG reduce methionine synthase reactivation efficiency, especially with low vitamin B12?

The MTRR gene encodes methionine synthase reductase (MSR), an essential enzyme responsible for maintaining methionine synthase (MTR) in its active state. The common MTRR rs1801394 (A66G) polymorphism directly influences the efficiency of this regenerative cycle.

Biochemical mechanisms

• Cofactor oxidation: During normal folate-cycle catalysis, the active cob(I)alamin cofactor of MTR inevitably becomes oxidized to an inactive cob(II)alamin state.
• Enzymatic reactivation: Under normal conditions, MSR utilizes flavins and S-adenosylmethionine (SAM) to re-reduce inactive cob(II)alamin back to active cob(I)alamin, ensuring continuous MTR activity.
• Structural alteration: The rs1801394 polymorphism results in an isoleucine-to-methionine substitution (Ile22Met) within the FMN-binding domain of MSR. This alteration lowers the enzyme's affinity for MTR, reducing its reactivation kinetics and overall catalytic efficiency.
• Intermediate state: Individuals carrying the heterozygous AG genotype exhibit moderately reduced MSR activity, representing a functional middle ground between the wild-type AA genotype and the homozygous variant GG genotype.

Clinical implications and vitamin B12 interaction

• Nutritional buffering: In individuals with the AG genotype, optimal vitamin B12 levels can buffer the moderately reduced enzymatic efficiency by providing an abundance of the cofactor.
• Exacerbation by suboptimal B12: When vitamin B12 levels are suboptimal, the MSR reactivation defect is severely exacerbated. The variant enzyme cannot efficiently recruit and regenerate the scarce cobalamin molecules.
• Functional deficiency: This synergy leads to cellular-level functional cobalamin deficiency and impaired homocysteine remethylation, culminating in elevated plasma homocysteine levels (hyperhomocysteinemia) even if serum B12 levels appear normal.

Bottom line

• The MTRR rs1801394 AG genotype moderately reduces methionine synthase reactivation efficiency due to impaired enzyme-cofactor affinity. This genetic impairment is highly sensitive to nutritional status, with suboptimal vitamin B12 levels severely compounding the defect and driving functional B12 deficiency and elevated homocysteine.